Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA.
Int J Radiat Biol. 2021;97(sup1):S151-S167. doi: 10.1080/09553002.2020.1820599. Epub 2020 Sep 24.
To address confounding issues that have been noted in planning and conducting studies to identify biomarkers of radiation injury, develop animal models to simulate these injuries, and test potential medical countermeasures to mitigate/treat damage caused by radiation exposure.
The authors completed an intensive literature search to address several key areas that should be considered before embarking on studies to assess efficacy of medical countermeasure approaches in mouse models of radiation injury. These considerations include: (1) study variables; (2) animal selection criteria; (3) animal husbandry; (4) medical management; and (5) radiation attributes.
It is important to select mouse strains that are capable of responding to the selected radiation exposure (e.g. genetic predispositions might influence radiation sensitivity and proclivity to certain phenotypes of radiation injury), and that also react in a manner similar to humans. Gender, vendor, age, weight, and even seasonal variations are all important factors to consider. In addition, the housing and husbandry of the animals (i.e. feed, environment, handling, time of day of irradiation and animal restraint), as well as the medical management provided (e.g. use of acidified water, antibiotics, routes of administration of drugs, consideration of animal numbers, and euthanasia criteria) should all be addressed. Finally, the radiation exposure itself should be tightly controlled, by ensuring a full understanding and reporting of the radiation source, dose and dose rate, shielding and geometry of exposure, while also providing accurate dosimetry. It is important to understand how all the above factors contribute to the development of radiation dose response curves for a given animal facility with a well-defined murine model.
Many potential confounders that could impact the outcomes of studies to assess efficacy of a medical countermeasure for radiation-induced injuries are addressed, and recommendations are made to assist investigators in carrying out research that is robust, reproducible, and accurate.
为了解决在规划和开展研究以确定辐射损伤生物标志物、开发模拟这些损伤的动物模型以及测试潜在的医学对策以减轻/治疗辐射暴露引起的损伤时所注意到的混杂问题。
作者进行了深入的文献检索,以解决在评估辐射损伤小鼠模型中医学对策方法的疗效之前应考虑的几个关键领域。这些考虑因素包括:(1)研究变量;(2)动物选择标准;(3)动物饲养;(4)医疗管理;和(5)辐射属性。
选择能够对所选辐射暴露做出反应的小鼠品系(例如,遗传倾向可能会影响辐射敏感性和对某些辐射损伤表型的倾向)并且以与人类相似的方式反应非常重要。性别、供应商、年龄、体重,甚至季节性变化都是需要考虑的重要因素。此外,动物的饲养和管理(即饲料、环境、处理、辐照的一天中的时间和动物约束)以及提供的医疗管理(例如使用酸化水、抗生素、药物给药途径、考虑动物数量和安乐死标准)都应该得到解决。最后,辐射暴露本身应该受到严格控制,通过确保充分了解和报告辐射源、剂量和剂量率、屏蔽和暴露几何形状,同时提供准确的剂量测定。了解所有上述因素如何共同为具有明确小鼠模型的特定动物设施的辐射剂量反应曲线的发展做出贡献非常重要。
解决了许多可能影响评估辐射诱导损伤的医学对策疗效的研究结果的潜在混杂因素,并提出了建议,以帮助研究人员进行稳健、可重复和准确的研究。